Alps Group Inc (ALPS) vs Connect Biopharma Holdings Limited (CNTB)
A side-by-side comparison of Alps Group Inc and Connect Biopharma Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALPS
Alps Group Inc
$0.38HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
CNTB
Connect Biopharma Holdings Limited
$0.96HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ALPS vs CNTB
growth of $100 · dividends reinvested · last 1yALPS -96.7% (-96.7%/yr)CNTB -47.2% (-47.2%/yr)CNTB compounded faster over this window
Log scale — wide-divergence pair
ALPS CNTB
ALPS vs CNTB: by the numbers
- •ALPS is the larger company ($63M vs $60M market cap).
- •Both run net losses; ALPS's is the smaller (-41.36% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | ALPS | CNTB |
|---|---|---|
| P/B ratio | N/A | 2.25 |
Profitability
| Metric | ALPS | CNTB |
|---|---|---|
| Gross margin | 32.09% | 100.00% |
| Operating margin | -69.62% | -90740.62% |
| Net margin | -41.36% | -86687.50% |
| ROE | N/A | -132.16% |
| ROIC | N/A | -136.77% |
Growth (annualized)
| Metric | ALPS | CNTB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -47.22% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.